Geneos Wealth Management’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.3M | Buy |
457,832
+128,868
| +39% | +$8.51M | 0.68% | 29 |
|
|
2025
Q4 | $20.6M | Buy |
328,964
+17,324
| +6% | +$1.06M | 0.5% | 42 |
|
|
2025
Q3 | $18.7M | Sell |
311,640
-240,820
| -44% | -$14M | 0.47% | 46 |
|
|
2025
Q2 | $31.5M | Sell |
552,460
-225,604
| -29% | -$12.1M | 0.77% | 15 |
|
|
2025
Q1 | $57.4M | Buy |
778,064
+474,660
| +156% | +$24M | 0.83% | 15 |
|
|
2024
Q4 | $14.5M | Buy |
303,404
+7,048
| +2% | +$354K | 0.51% | 34 |
|
|
2024
Q3 | $15.7M | Buy |
296,356
+38,648
| +15% | +$1.97M | 0.6% | 30 |
|
|
2024
Q2 | $12.7M | Buy |
257,708
+10,028
| +4% | +$499K | 0.57% | 34 |
|
|
2024
Q1 | $12.4M | Buy |
247,680
+1,640
| +0.7% | +$79.2K | 0.57% | 34 |
|
|
2023
Q4 | $11.8M | Buy |
246,040
+9,605
| +4% | +$430K | 0.58% | 36 |
|
|
2023
Q3 | $10.3M | Buy |
236,435
+51,300
| +28% | +$2.35M | 0.53% | 37 |
|
|
2023
Q2 | $8.55M | Buy |
185,135
+65,686
| +55% | +$3.02M | 0.45% | 42 |
|
|
2023
Q1 | $5.4M | Buy |
119,449
+24,355
| +26% | +$1.08M | 0.33% | 73 |
|
|
2022
Q4 | $3.99M | Sell |
95,094
-11,313
| -11% | -$458K | 0.24% | 110 |
|
|
2022
Q3 | $3.87M | Sell |
106,407
-4,483
| -4% | -$183K | 0.27% | 93 |
|
|
2022
Q2 | $4.53M | Buy |
110,890
+6,375
| +6% | +$283K | 0.22% | 108 |
|
|
2022
Q1 | $5.02M | Sell |
104,515
-2,976
| -3% | -$145K | 0.22% | 111 |
|
|
2021
Q4 | $5.49M | Buy |
107,491
+7,678
| +8% | +$394K | 0.21% | 108 |
|
|
2021
Q3 | $5.05M | Buy |
99,813
+6,662
| +7% | +$346K | 0.19% | 124 |
|
|
2021
Q2 | $4.83M | Sell |
93,151
-96,879
| -51% | -$5M | 0.19% | 127 |
|
|
2021
Q1 | $9.6M | Sell |
190,030
-1,669
| -0.9% | -$81.5K | 0.27% | 85 |
|
|
2020
Q4 | $4.53M | Buy |
191,699
+117,924
| +160% | +$5.19M | 0.18% | 138 |
|
|
2020
Q3 | $2.98M | Sell |
73,775
-12,083
| -14% | -$496K | 0.15% | 149 |
|
|
2020
Q2 | $3.3M | Sell |
85,858
-7,695
| -8% | -$281K | 0.18% | 127 |
|
|
2020
Q1 | $3.07M | Sell |
93,553
-62,682
| -40% | -$2.51M | 0.21% | 115 |
|
|
2019
Q4 | $6.9M | Sell |
156,235
-9,356
| -6% | -$399K | 0.37% | 63 |
|
|
2019
Q3 | $6.78M | Buy |
165,591
+2,719
| +2% | +$111K | 0.4% | 54 |
|
|
2019
Q2 | $6.79M | Sell |
162,872
-3,460
| -2% | -$143K | 0.42% | 53 |
|
|
2019
Q1 | $6.8M | Sell |
166,332
-46,699
| -22% | -$1.87M | 0.45% | 46 |
|
|
2018
Q4 | $7.96M | Sell |
213,031
-12,223
| -5% | -$484K | 0.59% | 31 |
|
|
2018
Q3 | $9.6M | Sell |
225,254
-127,335
| -36% | -$5.49M | 0.64% | 22 |
|
|
2018
Q2 | $15.1M | Buy |
352,589
+10,804
| +3% | +$482K | 1.18% | 8 |
|
|
2018
Q1 | $15.2M | Buy |
341,785
+185,126
| +118% | +$8.4M | 1.33% | 8 |
|
|
2017
Q4 | $7.03M | Buy |
156,659
+29,034
| +23% | +$1.28M | 0.63% | 32 |
|
|
2017
Q3 | $5.56M | Buy |
127,625
+26,658
| +26% | +$1.13M | 0.55% | 38 |
|
|
2017
Q2 | $4.17M | Buy |
100,967
+19,087
| +23% | +$778K | 0.43% | 63 |
|
|
2017
Q1 | $3.33M | Buy |
81,880
+1,216
| +2% | +$46.6K | 0.35% | 78 |
|
|
2016
Q4 | $2.95M | Buy |
80,664
+60,906
| +308% | +$2.22M | 0.39% | 72 |
|
|
2016
Q3 | $739K | Buy |
19,758
+1,456
| +8% | +$53.5K | 0.1% | 197 |
|
|
2016
Q2 | $648K | Buy |
18,302
+2,937
| +19% | +$106K | 0.09% | 201 |
|
|
2016
Q1 | $545K | Buy |
+15,365
| New | +$530K | 0.08% | 222 |
|
Other funds holding VEA
Geneos Wealth Management's VEA Position: Q1 2026 in Review
Geneos Wealth Management increased its Vanguard FTSE Developed Markets ETF (VEA) stake by 39% in Q1 2026, buying an estimated $8.51M and bringing the position to 457,832 shares worth $29.3M. The position accounts for 0.68% of the portfolio, ranked #29.
Geneos Wealth Management first reported a position in VEA in Q1 2016 and has held it in 41 quarters since. The position peaked at $57.4M in Q1 2025. 2,891 funds tracked by Wall St. Rank hold VEA as of Q1 2026.
- Geneos Wealth Management held 457,832 shares of Vanguard FTSE Developed Markets ETF worth $29.3M as of Q1 2026.
- Geneos Wealth Management bought 128,868 Vanguard FTSE Developed Markets ETF shares in Q1 2026, an estimated $8.51M.
- Vanguard FTSE Developed Markets ETF made up 0.68% of Geneos Wealth Management's portfolio in Q1 2026, its #29 holding.
- Geneos Wealth Management first reported a position in Vanguard FTSE Developed Markets ETF in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Vanguard FTSE Developed Markets ETF position peaked at $57.4M in Q1 2025.
- 2,891 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.